ORTHO TRI-CYCLEN LO (ETHINYL ESTRADIOL; NORGESTIMATE) — FDA Approval NDA021241 (JANSSEN PHARMS)
ORTHO TRI-CYCLEN LO (ETHINYL ESTRADIOL; NORGESTIMATE) — FDA Approval NDA021241 (JANSSEN PHARMS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ORTHO TRI-CYCLEN LO; Active ingredients: ETHINYL ESTRADIOL; NORGESTIMATE; Application number: NDA021241.
| Brand name | ORTHO TRI-CYCLEN LO |
|---|---|
| Active ingredients | ETHINYL ESTRADIOL; NORGESTIMATE |
| Application number | NDA021241 |
| Sponsor | JANSSEN PHARMS |
| Dosage form | TABLET |
| Route | ORAL-28 |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20020822 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →